SCHEMBL1218808

SCHEMBL1218808

CN(C)CCOc1ccccc1CN(C)S(=O)(=O)c1cc(-c2ccnn2-c2ccccc2Cl)c(O)cc1O

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 7/20 0.45
NR3C2 P08235 1/20 0.34
FABP3 P05413 1/20 0.34
FABP4 P15090 1/20 0.34
ROCK2 O75116 1/20 0.33
ROCK1 Q13464 1/20 0.33
P2RX7 Q99572 1/20 0.33
HRH1 P35367 1/20 0.33
DRD2 P14416 1/20 0.33
DRD1 P21728 1/20 0.33
DRD4 P21917 1/20 0.33
DRD5 P21918 1/20 0.33
KDM4E B2RXH2 3/20 0.33
LMNA P02545 1/20 0.33
HTR7 P34969 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
ALDH1A1 P00352 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1218721 0.93 HSP90AA1 (0.46) HSP90AA1NR3C2FABP3FABP4P2RX7
SCHEMBL1218910 0.92 HSP90AA1 (0.45) HSP90AA1NR3C2FABP3FABP4P2RX7
SCHEMBL2077566 0.91 HSP90AA1 (0.47) HSP90AA1NR3C2HRH1DRD2DRD1
SCHEMBL1219049 0.91 HSP90AA1 (0.44) HSP90AA1NR3C2FABP3FABP4P2RX7
SCHEMBL1216550 0.91 HSP90AA1 (0.45) HSP90AA1NR3C2HRH1DRD2DRD1
SCHEMBL1218307 0.90 HSP90AA1 (0.47) HSP90AA1NR3C2P2RX7SMN1; SMN2
SCHEMBL1218902 0.90 HSP90AA1 (0.44) HSP90AA1NR3C2FABP3FABP4
SCHEMBL1216013 0.89 HSP90AA1 (0.45) HSP90AA1NR3C2KDM4ELMNAALDH1A1
SCHEMBL1215349 0.89 HSP90AA1 (0.42) HSP90AA1NR3C2FABP3FABP4DRD2
SCHEMBL1217338 0.87 HSP90AA1 (0.51) HSP90AA1NR3C2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7906657-B2 1,5-diphenylpyrazoles II as HSP90 inhibitors MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2011-03-15 US claimed
US-20090325974-A1 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS MERCK PATENT GESELLSCHAFT (DE) 2009-12-31 US claimed
US-7906657-B2 1,5-diphenylpyrazoles II as HSP90 inhibitors MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2011-03-15 US disclosed
US-20110028485-A1 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS EGGENWEILER HANS-MICHAEL 2011-02-03 US disclosed
US-20090325974-A1 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS MERCK PATENT GESELLSCHAFT (DE) 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325974-A1 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885NR3C2 570/4885FABP3 1037/4885
US-20110028485-A1 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885NR3C2 570/4885FABP3 1037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.